Cargando…

Integrated Analysis of Gut Microbiome and Liver Metabolome to Evaluate the Effects of Fecal Microbiota Transplantation on Lipopolysaccharide/D-galactosamine-Induced Acute Liver Injury in Mice

Acute liver failure (ALF) refers to the occurrence of massive hepatocyte necrosis in a short time, with multiple complications, including inflammatory response, hepatic encephalopathy, and multiple organ failure. Additionally, effective therapies for ALF are lacking. There exists a relationship betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Chunchun, Fan, Jinghui, Jiang, Lai, Ye, Wenxin, Chen, Zhuo, Wu, Wenzi, Huang, Qixin, Qian, Lichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005546/ https://www.ncbi.nlm.nih.gov/pubmed/36904149 http://dx.doi.org/10.3390/nu15051149

Ejemplares similares

Akkermansia and its metabolites play key roles in the treatment of campylobacteriosis in mice
por: Jiang, Lai, et al.
Publicado: (2023)

Guanabenz Prevents d-Galactosamine/Lipopolysaccharide-Induced Liver Damage and Mortality
por: Perego, Jessica, et al.
Publicado: (2017)

Co-administration of lipopolysaccharide and d-galactosamine induces genotoxicity in mouse liver
por: Dong, Wenjing, et al.
Publicado: (2021)

The Protective Effect of Cordycepin on D-Galactosamine/Lipopolysaccharide-Induced Acute Liver Injury
por: Li, Jin, et al.
Publicado: (2017)

Protective Role of Mytilus edulis Hydrolysate in Lipopolysaccharide-Galactosamine Acute Liver Injury
por: Starikova, Eleonora, et al.
Publicado: (2021)

Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury
por: Yu, Lei, et al.
Publicado: (2017)

Combining fecal microbiome and metabolomics to reveal the disturbance of gut microbiota in liver injury and the therapeutic mechanism of shaoyao gancao decoction
por: Li, Jingwei, et al.
Publicado: (2022)

The Protection of Midazolam Against Immune Mediated Liver Injury Induced by Lipopolysaccharide and Galactosamine in Mice
por: Li, Jian, et al.
Publicado: (2019)

Deficiency of interleukin-19 exacerbates lipopolysaccharide/D-galactosamine-induced acute liver failure
por: FUJIMOTO, Yasuyuki, et al.
Publicado: (2020)

Carfilzomib Mitigates Lipopolysaccharide/D-Galactosamine/Dimethylsulfoxide-Induced Acute Liver Failure in Mice
por: Alhareth, Dhafer Y., et al.
Publicado: (2023)

The Protective Role of Pregnane X Receptor in Lipopolysaccharide/D-galactosamine-induced Acute Liver Injury
por: Wang, Kun, et al.
Publicado: (2009)

Intraperitoneal Administration of Fetuin-A Attenuates d-Galactosamine/Lipopolysaccharide-Induced Liver Failure in Mouse
por: Zhang, Pan, et al.
Publicado: (2014)

Protective Effects of Costunolide Against D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice
por: Mao, Jingxin, et al.
Publicado: (2018)

Recovery of the Gut Microbiome following Fecal Microbiota Transplantation
por: Seekatz, Anna M., et al.
Publicado: (2014)

Metabonomic analysis of liver tissue from BALB/c mice with d-galactosamine/lipopolysaccharide-induced acute hepatic failure
por: Feng, Bo, et al.
Publicado: (2013)

Chicoric acid ameliorate inflammation and oxidative stress in Lipopolysaccharide and d‐galactosamine induced acute liver injury
por: Li, Zheng, et al.
Publicado: (2020)

Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice
por: Wu, Yi-Long, et al.
Publicado: (2022)

Fecal Microbiota Transplantation in Liver Cirrhosis
por: Boicean, Adrian, et al.
Publicado: (2023)

Alleviation of lipopolysaccharide/d-galactosamine-induced liver injury in leukocyte cell-derived chemotaxin 2 deficient mice
por: Okumura, Akinori, et al.
Publicado: (2017)

Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway
por: Pan, Chen-wei, et al.
Publicado: (2017)

The fecal metabolome as a functional readout of the gut microbiome
por: Zierer, Jonas, et al.
Publicado: (2018)

Research Progress of Fecal Microbiota Transplantation in Liver Diseases
por: Zhao, Yuanyuan, et al.
Publicado: (2023)

The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review
por: Zhang, Xianzhuo, et al.
Publicado: (2023)

Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota
por: Fang, Daiqiong, et al.
Publicado: (2017)

Protective effect of ultrasonication-processed ginseng berry extract on the D-galactosamine/lipopolysaccharide-induced liver injury model in rats
por: Nam, Yoonjin, et al.
Publicado: (2018)

Nrf2 signaling and autophagy are complementary in protecting lipopolysaccharide/d-galactosamine-induced acute liver injury by licochalcone A
por: Lv, Hongming, et al.
Publicado: (2019)

Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice
por: Mohamadi-Zarch, Seyed-Mahdi, et al.
Publicado: (2021)

Adenosine 5′-monophosphate ameliorates D-galactosamine/lipopolysaccharide-induced liver injury through an adenosine receptor-independent mechanism in mice
por: Zhan, Y, et al.
Publicado: (2014)

Catalpol protects mice against Lipopolysaccharide/D-galactosamine-induced acute liver injury through inhibiting inflammatory and oxidative response
por: Zhang, Haogang, et al.
Publicado: (2017)

Interleukin-35 Attenuates D-Galactosamine/Lipopolysaccharide-Induced Liver Injury via Enhancing Interleukin-10 Production in Kupffer Cells
por: Zheng, Xing-Feng, et al.
Publicado: (2018)

Protective Role of Shiitake Mushroom-Derived Exosome-Like Nanoparticles in D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice
por: Liu, Baolong, et al.
Publicado: (2020)

The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation
por: Henig, Israel, et al.
Publicado: (2020)

Levosimendan Increases Survival in a D-Galactosamine and Lipopolysaccharide Rat Model
por: Sakaguchi, Tatsuma, et al.
Publicado: (2022)

Fecal microbiota transplantation in alcohol related liver diseases
por: Shasthry, Saggere Muralikrishna
Publicado: (2020)

Spred2 Deficiency Exacerbates D-Galactosamine/Lipopolysaccharide -induced Acute Liver Injury in Mice via Increased Production of TNFα
por: Yang, Xu, et al.
Publicado: (2018)

Short‐term fasting attenuates lipopolysaccharide/D‐galactosamine‐induced acute liver failure through Sirt1‐autophagy signaling in mice
por: Long, Boyu, et al.
Publicado: (2023)

Fecal microbiota transplantation improves metabolism and gut microbiome composition in db/db mice
por: Zhang, Pei-pei, et al.
Publicado: (2020)

An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection
por: Antharam, Vijay C., et al.
Publicado: (2016)

Gut Microbiota and Fecal Metabolome Perturbation in Children with Autism Spectrum Disorder
por: Mohamadkhani, Ashraf
Publicado: (2018)

2517. Oral Fecal Microbiota Transplantation Increases Gut Microbiome Diversity and Alters the Microbiome Distribution in People with HIV
por: Utay, Netanya S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fe8md9i1bk6iega608omcsujge